Abstract-Renin, a key component in the regulation of blood pressure in mammals, is produced by the rare and highly specialized juxtaglomerular cells of the kidney. Chronic stimulation of renin release results in a recruitment of new juxtaglomerular cells by the apparent conversion of adjacent smooth muscle cells along the afferent arterioles. Because juxtaglomerular cells rapidly dedifferentiate when removed from the kidney, their developmental origin and the mechanism that explains their phenotypic plasticity remain unclear. To overcome this limitation, we have performed RNA expression analysis on 4 human renin-producing tumors. The most highly expressed genes that were common between the reninomas were subsequently used for in situ hybridization in kidneys of 5-day-old mice, adult mice, and adult mice treated with captopril. From the top 100 genes, 10 encoding for ligands were selected for further analysis. Medium of human embryonic kidney 293 cells transfected with the mouse cDNA encoding these ligands was applied to (pro)renin-synthesizing As4.1 cells. Among the ligands, only platelet-derived growth factor B reduced the medium and cellular (pro)renin levels, as well as As4.1 renin gene expression. In addition, platelet-derived growth factor B-exposed As4.1 cells displayed a more elongated and aligned shape with no alteration in viability. This was accompanied by a downregulated expression of α-smooth muscle actin and an upregulated expression of interleukin-6, suggesting a phenotypic shift from myoendocrine to inflammatory. Our results add 36 new genes to the list that characterize renin-producing cells and reveal a novel role for platelet-derived growth factor B as a regulator of renin-synthesizing cells.
T he aspartyl protease renin catalyzes the rate-limiting step in the renin-angiotensin system. Renin is produced almost exclusively by the so-called juxtaglomerular cells that line the afferent arterioles at their point of entry into the kidney glomeruli. Juxtaglomerular cells convert renin from its inactive precursor (prorenin) by proteolysis and store the resulting active renin in lysosome-like dense cytoplasmic granules whose content can be rapidly released in response to such stimuli as a sudden drop in the perfusion pressure of the afferent arteriole or β-adrenergic stimulation. During kidney development, reninproducing cells are more broadly distributed along the lumen of the nascent arterioles 1 and gradually become restricted to the glomerular poles after birth. Prolonged exposure to stimuli, such as blood pressure-lowering medication, a low-salt diet, or ischemia results in an apparent recruitment of new reninproducing cells along the afferent arterioles, 2 which has been proposed to represent a partial return to the developmental pattern of juxtaglomerular cell distribution. Altogether, renin-producing juxtaglomerular cells display many unique biological features, and because of their central role in modulating blood pressure and fluid balance, there has been long-standing interest in obtaining a better understanding of their origins and biology.
Efforts to characterize juxtaglomerular cells have historically been hampered by 2 factors: first, juxtaglomerular cells rapidly dedifferentiate when placed in culture, losing their secretory granules and, concomitantly, their ability to proteolytically activate prorenin. As a result, attempts to immortalize both mouse and human renin-producing cells have resulted in the establishment of cell lines that have lost the ability to secrete renin. 3, 4 Second, juxtaglomerular cells make up <0.1% of the cell mass of the kidney, making it difficult to isolate sufficient quantities of pure cells for further characterization. As an alternative approach, Brunskill et al 5 targeted yellow fluorescent protein to mouse juxtaglomerular cells and used fluorescence-activated cell sorting to enrich tagged cells for expression analysis. The resulting study proposed a 369 gene signature that characterizes mouse juxtaglomerular cells although few of these have been verified in subsequent studies.
In an effort to extend these studies and to determine whether the genes identified in the mouse also characterize human renin-producing cells, we have catalogued the gene expression pattern of biopsies derived from 4 human reninproducing tumors or reninomas. Reninomas are rare, benign tumors arising from a proliferation of juxtaglomerular cells in the kidney cortex 6, 7 and are often detected because of the appearance of fulminant hypertension in relatively young patients (mean age <30 years) with no obvious explanatory risk factors. RNA sequencing revealed a set of 54 highly expressed genes that are common to all 4 tumors and another 30 expressed in 3 of the 4 biopsies tested. In situ hybridization of mouse kidney sections subsequently confirmed juxtaglomerular cell expression of 44 of these genes, the vast majority of which have not been reported previously to be expressed in juxtaglomerular cells. Finally, hypothesizing that the highly expressed reninoma genes affect renin-synthesizing capacity, we selected 10 ligands (based on known relevance for blood pressure and kidney disease) and studied their effects on (pro)renin release by As4.1 cells. These cells are derived from a transgene-induced mouse kidney tumor and do not store renin. They may thus be considered as dedifferentiated juxtaglomerular cells that have lost their capacity to secrete lysosomes. Consequently, As4.1 cells might serve as a model to study the effect of reninoma-specific ligands on juxtaglomerular cell plasticity. Results revealed an unexpected suppressant role for platelet-derived growth factor B (PDGFB).
Methods

Human and Mouse Studies
Total RNA was isolated using Trizol (Invitrogen) from 4 reninomas surgically obtained from 4 anonymous patients (Paris1, Paris2, Montréal, and Rotterdam) and underwent RNA sequencing analysis using the HiSeq2000 (Illumina). The top 100 most upregulated genes presented in all 4, and at least in 3 of 4 reninomas were submitted to immunofluorescence and fluorescent in situ hybridization to analyze their expression in the juxtaglomerular apparatus of the kidney of mice under different situations (5 days old, 10 to 12 weeks old, and 10 to 12 weeks old treated with captopril for 7 days). For further details, see the Methods in the online-only Data Supplement.
Cell Culture Studies
Human embryonic kidney (HEK) 293 cells were transfected with plasmids encoding ligands selected from the transcriptome analysis on 4 reninomas. The conditioned medium derived from these cells was used to study the effect of these ligands on (pro)renin-synthesizing As4.1 cells. For further details, see the Methods in the online-only Data Supplement.
Statistical Analysis
Results are expressed as mean±SEM. Data were analyzed for normal distribution using a Shapiro-Wilk test (P>0.05). Differences were tested using 1-way or 2-way ANOVA, followed by Holm-Sidak or Dunnett multiple comparison test. P<0.05 was considered significant.
Results
Deep sequencing of RNA was performed on 3 biopsies of a first reninoma from Paris (Par1B1-B3), 1 biopsy from a reninoma from Montréal (Mon), 2 biopsies from a reninoma from Rotterdam (RotB1 and B2), and a second reninoma from Paris (Par2) along with a biopsy from adjacent supposedly normal tissue from the same patient (Par2N; Table S1 in the onlineonly Data Supplement). We obtained from 45 to 100 million reads per sample (Table 1 ) with comparable overall sample quality ( Figure S1 ). Remarkably, the fragments per kilobase of transcript per million mapped reads values for renin were similar in the 4 tumor samples and, in each tumor, renin was expressed at 15 to 41 times the level of the next most abundant transcript, confirming the diagnosis of bona fide reninomas (Table 2) .
Results obtained from the 3 independently analyzed biopsies of the Paris1 reninoma demonstrated an intersample Spearman correlation of >0.98 ( Figure S2 , red outlines), and similar results were obtained with the 2 of the reninoma from Rotterdam ( Figure S2 , green outlines), suggesting that the sample preparation and results obtained were reliable and reproducible. In the 1 case in which we had biopsies of both tumor and adjacent tissue from a single patient (Paris2), there was a 217-fold increase in the number of renin reads in the reninoma versus the normal sample (Table 2 ) although the samples overall were highly correlated (0.92 for all genes; Figure  S2 , blue outlines). By limiting the gene set analyzed in all the samples to those that were expressed at least 4-fold higher in the reninoma versus the normal biopsies for Paris2, we reduced the gene set to just >1000 (Table S2 ) and this resulted in the removal of low reads (which are commonly unreliable) and many housekeeping genes from the analysis. Using this limited gene set, we identified the 100 most-expressed genes in each biopsy (Table S3 ). Recalculation of the Spearman correlation using these highly expressed genes revealed a higher discrimination between samples ( Figure S3 ). Although the repeat biopsies continued to exhibit a correlation of >0.98, the ) . Surprisingly, the highest correlation is between the Par2 and Par2N samples (0.81; Figure S3 ), raising the possibility that the supposedly normal sample from this patient contains some reninoma. A Venn diagram reveals that 54 of the 100 most expressed genes were common to all 4 reninomas (Table S3 ; Figure S4 ), and another 30 genes were highly expressed in 3 of 4 of the tumors analyzed. Functional annotation clustering analysis (DAVID [Database for Annotation, Visualization and Integrated Discovery]) did not reveal any statistically significant correlation for cellular function using the genes most commonly expressed in the reninomas (data not shown).
To test whether these reninoma-enriched genes were also expressed in juxtaglomerular cells, we performed immunofluorescence and fluorescent in situ hybridization for 71 of the above 84 common reninoma transcripts (excluding, among others, genes that have no mouse equivalent) in kidney sections from C57bl/6 mice using the equivalent mouse probes (Table 3; Figure S5 ). As expected, combined in situ hybridization and immunofluorescence for renin reveals perfect colocalization in the juxtaglomerular cells of adult mice ( Figure 1A through 1D). Furthermore, treatment of the mice with captopril for 1 week resulted in the expected recruitment of juxtaglomerular cells along the afferent arterioles ( Figure 1E ), whereas colocalization was also observed throughout the maturing arterioles of 5-day-old mice ( Figure 1F ). These results confirm the validity of this approach to assess the colocalization of the transcripts from the reninoma in the mouse juxtaglomerular cells.
To obtain a semiquantitative comparison of gene expression levels in renin-producing cells, all confocal microscopy images were taken using the same parameters and a ranking from 0 (for no expression observed) to 4 (highly expressed) was assigned for each gene under each condition tested (Table 3) . Among the 71 genes tested, 44 genes are expressed in both reninomas and mouse juxtaglomerular cells. Twenty-four of these were detected in all 3 conditions (5-day-old mice, adult mice, and adult mice treated with captopril kidneys), whereas the remainder showed preferential expression in ≥1 conditions ( Figure S5 ; Table 3 ). Functional annotation clustering analysis using the 44 genes expressed in both the reninomas and mouse juxtaglomerular cells identified developmental processes as the most likely gene ontology (data not shown).
From the top 100 highly expressed genes, focusing on blood pressure regulation and renal disease, we selected 10 genes coding for ligands (FSTL1, IGF2, LGALS1, MDK, MFGE8, NPPC, PDGFB, SPARC, SPARCL1, and WFDC2) to investigate their potential role in juxtaglomerular recruitment. The corresponding mouse cDNAs were cloned with a c-myc epitope and transfected into HEK293 cells to obtain high concentrations of these ligands in the supernatant of the culture medium. Western blot experiments confirmed the presence of the proteins of each of the transfected genes in the HEK293 cell medium at 48 hours after transfection ( Figure  S6 ). Because all ligands were tagged with a c-myc epitope, the same primary antibody could be used.
After adding the 48-hour conditioned HEK293 medium (containing the highest level of the desired protein) to (pro)renin-producing As4.1 cells for 2 days, we studied As4.1 cell morphology and quantified (pro)renin in the medium. Only PDGFB altered As4.1 cell morphology, in that the cells after exposure to this ligand displayed a more elongated densely packed and aligned shape ( Figure S7 ). Moreover, PDGFB also induced parallel decreases in the medium and cellular (pro)renin levels, by 64±5 and 53±10%, respectively (n=11) although only the former was significant (P=0.03; Figure 2A ). Under control conditions, the medium contained predominantly (>95%) prorenin. In contrast, the cell lysate contained renin only, at levels corresponding to <1% of the total amount of renin+prorenin in the medium. Quantitative polymerase chain reaction experiments revealed that the reduction in (pro)renin also occurred at the expression level, decreasing this by 84±5% (P=0.005; n=5; Figure 2A ). Furthermore, when applying commercially obtained PDGFB directly to As4.1 cells, it lowered (pro)renin concentration dependently ( Figure 2B ), and from these data, it could be estimated that the PDGFB level in the conditioned HEK293 medium was >100 ng/mL. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assays confirmed that the effect of PDGFB was not because of a reduction in cell viability ( Figure 2B ). Moreover, PDGFB did not affect total protein content, suggesting that its effect was also not because of a decrease in cell number (data not shown).
Finally, we evaluated the effect of PDGFB-containing HEK293 medium on the expression of markers that illustrate the occurrence of a smooth muscle, endocrine, and immunologic phenotype, that is, aldo-keto reductase family 1, member B7 (Akr1b7), α-smooth muscle actin (Acta2), interleukin-6, and recombination signal binding protein for immunoglobulin kappa j (Rbpj). Figure 2C illustrates that PDGFB upregulated interleukin-6 (P<0.0001; n=4) and downregulated Acta2 (P=0.01; n=6) in As4.1 cells. Nonsignificant increases in Akr1b7 (P=0.06, n=4) and Rbpj (P=0.06, n=5) expression were also observed.
Discussion
The aim of this study was to gain insight into human juxtaglomerular cell biology. Given their rapid dedifferentiation in culture, such knowledge is currently lacking. Instead, information on renin synthesis is largely derived from renin-producing tumor-derived cell lines, like As4.1 (mouse), Calu-6 (human), and human mastocytoma cells. In an attempt to catalogue the genes expressed in juxtaglomerular cells, Brunskill et al 5 used a fluorescent reporter mouse model, in which they have used cell sorting to enrich for gene-tagged renin-expressing cells in the mouse kidney. Comparison of gene expression arrays from the sorted cells versus the whole kidney led to the identification of 369 core genes whose expression was proposed to constitute a gene signature for the mouse juxtaglomerular cell. In the current study, we have used direct RNA sequencing of human reninomas to independently quantify gene expression levels in each of the biopsies we obtained and to test for correlation of the gene expression patterns between mouse and human reninexpressing cells. This approach has the additional advantage that a control tissue to which expression can be compared was not required. This was an important consideration because our samples were derived from frozen pathology specimens, and only one of them had a corresponding biopsy of adjacent, presumed nontumor, tissue. The high reproducibility and sequence depth achieved confirm that this approach is valid, robust, and applicable to archival samples and the comparison of the reninoma transcriptomes allowed us to derive a gene expression fingerprint for the tumors. In addition, the high expression of renin, CD34, and vimentin, all of which have been reported previously as markers of reninomas, 7, 8 confirms the diagnosis of bona fide reninoma in all of the tumors.
At least 3 of the 4 reninomas expressed genes at relatively high levels that were also reported to be highly expressed in mouse renin-expressing cells 5 including, in addition to renin, RGS5, CRIP1, and ATP1B2. Conversely, several of the most highly expressed transcripts previously identified in the mouse juxtaglomerular cell preparations were not detected in the 100 most-expressed genes in the reninomas including Syne2, Plac9, Myh11, Jph2, Myo18, Akr1b7, and Mgp. Interestingly, Akr1b7, a member of the α-keto reductase gene family was previously found to be highly enriched in mouse juxtaglomerular cell preparations and to serve as a specific marker for juxtaglomerular cells in the mouse kidney. 5 Even though Akr1b7 does not have a homologue in humans, its closest human analogues, AKR1B10 and AKR1B15, are not expressed at detectable levels in the reninomas (data not shown). Because more recent results have shown that targeted deletion of Akr1b7 in mouse juxtaglomerular cells does not affect renin production, 9 it is possible that the expression of Akr1b7 in mouse juxtaglomerular cells is unrelated to renin synthesis.
Indeed, of the extended list of 369 core genes reported previously to be enriched in the mouse renin cell preparations, 5 only 8 were among the 84 genes expressed in at least 3 of the 4 reninomas ( Table 3; Table S3 ). Although the exact reason for these differences is unclear, they could be because of several factors. First, some of the highly expressed transcripts in the reninomas might be related to the tumoral transformation of the renin-producing cells. For example, the expression of neither CD34, a commonly reported marker of reninomas and myelolymphopoetic precursors, nor insulinlike growth factor 2 was detected in the mouse juxtaglomerular cells. Insulin-like growth factor 2 also did not affect (pro)renin release by As4.1 cells. Alternatively, the differences The genes found to express in RPC are listed in their order of expression in the reninomas from highest to lowest (Table S1) , and their relative expression in each sample is estimated on a scale of 0 (no detectable expression) to 4 (highest expression), based on the data in Figure S5 . iFISH indicates immunofluorescence and fluorescent in situ hybridization; JG, juxtaglomerular; RPCs, renin-producing cells; and VSMCs, vascular smooth muscle cells.
*Described as part of a 369 gene list that makes up a renin-producing cell signature, according to Brunskill et al. 5 †Reported as reninoma marker. Of the genes confirmed by iFISH, 36 have not been reported before in relationship to RPCs. could be because of the fact that in both the current study and that of Brunskill et al, 5 the gene expression patterns were obtained from impure populations of renin-producing cells and could reflect expression of a gene in a contaminating nonjuxtaglomerular cell. Finally, they could reflect true differences between mouse and humans.
To overcome some of these limitations, we used immunofluorescence and fluorescent in situ hybridization to test whether the commonly expressed genes in the reninomas were also expressed in mouse juxtaglomerular cells ( Figure  S5 ). Even though the sensitivity of this analysis is limited by the level of expression of the candidate genes, it nevertheless confirmed that 44 of the gene transcripts expressed in the reninomas were also detected in mouse juxtaglomerular cells (Table 3 ) and thereby significantly extends the list of potential markers for this unique cell type.
Previous studies have reported that juxtaglomerular cells express contractile proteins, are related to pericytes 5 and, like pericytes, are derived from FoxD1-expressing lineages. 10 Simultaneously, renal CD44(+) mesenchymal stem cell-like cells, whose differentiation is triggered by LXR (liver X receptor) stimulation, 11 have been suggested to differentiate into juxtaglomerular-like renin-expressing cells. 12 The current analysis confirmed the expression of many contractile proteins in both reninomas and juxtaglomerular cells, including myosin light chain 9, tropomyosin 2, transgelin, myocyte enhancer factor 2C, caldesmon, and very low levels of ACTA2, as well as some pericyte markers including RGS5 and osteonectin (SPARC). We also confirmed the expression of vimentin (VIM), a marker of mesenchyme-derived cells, in both the reninomas and juxtaglomerular cells, but did not detect the expression of either LXR receptor or CD44 in the tumors.
Our data also call into question the model that recruited juxtaglomerular cells (eg, after captopril treatment) represent a return to the embryonic stage of renin-producing cells. The ACTA2 gene codes for α-smooth muscle actin, a marker for smooth muscle cells. Consistent with what has been reported previously, 13 there is a demarcation in Acta2 expression with the expected higher expression in smooth muscle cells of the afferent arteriole and low expression in adjacent juxtaglomerular cells of adult mice ( Figure 3A ). This demarcation persists after recruitment of new juxtaglomerular cells after captopril treatment ( Figure 3B ). In contrast, there seem to be 2 populations of renin-expressing cells in the developing kidney: one population that exists in clusters similar to the juxtaglomerular apparatus in adult kidney ( Figure 3C , arrow) and which express only low levels of ACTA2 and others that line the vessels of the developing kidney and exhibit significant overlap of renin staining and ACTA2 expression ( Figure 3C , light blue outline). Other genes whose expression was detected almost exclusively in renin-producing cells of the developing kidney include A2m, Slit3 and Cxcl12. Conversely, many genes seemed to be preferentially expressed in the juxtaglomerular cells of adult control and captopril-treated mice including Ptp4a3, C4a, Tinagl1, Lbh, Mdk, Bgn, and Crip1. Taken together, these results suggest that juxtaglomerular recruitment does not simply involve a return to the embryonic reninproducing cell, but may rather reflect differentiation of smooth muscle to either an intermediate or alternative phenotype.
KISS1, which codes for a metastasis suppressor and is the second to third most abundant transcript in each of the 4 of the reninomas (Table 3) , also presents a major difference in expression in the reninomas and mouse kidney. The KISS1 gene is located immediately adjacent to the renin gene on chromosome 1 in both mice and humans (http://www.ncbi. nlm.nih.gov/gene/3814). When large chromosomal fragments containing both genes are used to generate transgenic mice, coordinate expression of renin and KISS1 is detected in brain, kidney, lung, and placenta.
14 Although we detected some expression of Kiss1 in the juxtaglomerular cells of captopriltreated mice ( Figure S5 ), we did not detect its expression in adult mouse juxtaglomerular cells, raising the possibility that the neighboring Kiss1 gene is expressed only in conditions of high renin gene expression. Whether it explains the fact that intrarenal reninomas rarely metastasize is currently unknown.
Also among the most highly expressed genes in all 4 reninomas is DBNDD2 (Table S3) , a paralog of the gene DTNBP1, which is a component of the BLOC-1 complex that is required for normal biogenesis of lysosome-related organelles, such as platelet dense granules and melanosomes. Thus, DBNDD2 might be an interesting candidate to explain the high content of lysosome-related organelles found in the juxtaglomerular cells.
Many ligands and receptors were also found to be highly expressed in the reninomas and in mouse renin-producing cells, some of which might play a role in either the maintenance of the juxtaglomerular cell phenotype or in juxtaglomerular cell recruitment. Of particular interest is the high level of expression of the Notch3 receptor and PDGF receptor β (PDGFRβ) in the reninomas and juxtaglomerular cells. Indeed, RBPJ, the main effector involved in Notch receptor signaling, activates the myoendocrine program of the juxtaglomerular cell, and conditional deletion of Rbpj in renin-producing cells results in a dramatic decrease in the number of juxtaglomerular cells seen in adult mice. 15 Yet, in humans, mutations in NOTCH3 have been identified as the underlying cause of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), with no known effects on renin.
In the current study, we observed that PDGFB suppressed (pro)renin synthesis in As4.1 cells and altered their morphology. The concomitant suppression of Acta2 and upregulation of interleukin-6 suggests an As4.1 phenotype change from myoendocrine to inflammatory. Interleukin-6 upregulation by PDGFB is well known and occurs in an RBPJ-independent manner. 16 No significant alterations were observed in Akr1b7 and Rbpj, nor did PDGFB affect cell viability. Classically, endothelium-derived PDGFB recruits pericytes and promotes vascular smooth muscle cell proliferation. 17 Importantly, pericytes in the human kidney were recently reported to produce renin. 18 Hypoxia transforms renin-producing cells into erythropoietin-producing cells, 19 and erythropoietin-expressing cells are assumed to be derived from capillary pericytes. 20 Finally, after severe mesangial injury, renin-positive precursor cells moved into intraglomerular sites and differentiated into (reninnegative), PDGFRβ-expressing mesangial cells. 21 As shown in Figure 3D through 3F, PDGFRβ modestly overlapped with renin in kidneys of adult, young, and captopril-treated adult mice, in addition to its well-known expression in interstitial cells. Moreover, Rider et al 22 observed that renin cells in the zebrafish kidney express both Acta2 and Pdgfrβ. Given the well-known role of endothelial PDGFB as a facilitator of mesangial cell proliferation and migration, an additional effect of PDGFB might now be suppression of renin expression. Here, it should be mentioned that neither conditional deletion of the PDGFRβ in renin-producing cells nor deletion of endothelial PDGFB production affected the normal development of renal renin-expressing cells. 23 This may not be too surprising, given the fact that PDGFB actually is a negative regulator of renin expression, possibly coming into play only under pathological conditions.
Besides the high level of PDGFRβ expression in the reninomas and the juxtaglomerular cells, both also express the genes for SPARC, SPARCL1 (SPARC-like 1 or hevin), and MFGE8 (lactadherin) at relatively high levels. It has been reported that SPARC can both prevent the binding of PDGF to its receptor 24 and potentiate its profibrotic effects, 23 whereas lactadherin potentiates PDGFRβ signaling. 25 This raises the possibility that a more complex interplay between SPARC, SPARCL1, MFGE8, and PDGF regulates either the recruitment or other physiological responses of juxtaglomerular cells in their natural setting. In agreement with this concept, the current study revealed no effect of SPARC, SPARCL1, or MGE8 alone on (pro)renin synthesis by As4.1 cells. In addition, ligands that are known to be involved in blood pressure regulation (natriuretic peptide precursor C [NPPC]), diabetic nephropathy (LGALS1 or galectin-1), 26 nephrogenesis (MDK or midkine), 27 renal fibrosis (WFDC2 [WAP 4-disulfide core domain protein 2]), 28 and renal injury prevention (FSTL1 [follistatin-related protein 1]) 29 also did not directly affect (pro)renin synthesis by As4.1 cells.
Somewhat surprisingly, no proteases were included in the 100 most expressed genes in the reninomas (Table S3) where we might have expected to find ≥1 candidate prorenin-processing enzymes necessary for proteolytic activation of the renin secreted by these tumors. However, examination of the gene lists before subtraction of the genes expressed in the Par2N normal biopsy (Table S1 ) reveals that the rank of Cathepsin B (CTSB) expression varies from the eighth (Par1B1) to the 78th (Par2) position in the reninomas although these expression levels did not seem to correlate with the apparent renin expression levels in each sample (not shown). However, because CTSB was only expressed 1.1-fold more in the Par2 reninoma than in the Par2N control kidney biopsy, it was eliminated from our gene list. Nevertheless, because CTSB has been colocalized with renin in juxtaglomerular cells secretory granules 30 and shown to accurately process human prorenin in vitro, 31 it is possible that it fulfills the role of the prorenin-processing enzymes in the reninomas, even though it is a ubiquitously distributed protease. This analysis also reveals one of the potential shortcomings of our approach, because by focusing on genes whose expression was consistently enriched in tumor biopsies, we may have eliminated consideration of genes that play an important functional role in the biology of the juxtaglomerular cell, but whose expression is more widely distributed.
The present study is the first to use a reninoma transcriptome analysis as an approach to understand human juxtaglomerular cell biology. It has yielded multiple new candidates that might play a role in the developmental plasticity of these cells and, among them, raises the PDGFB-PDGFRβ signaling pathway as a promising novel pathway that controls reninexpressing cells.
Perspectives
By comparing the transcriptomes of 4 reninomas and subsequently mapping the expression patterns of the most highly expressed genes in mouse kidney during development, adulthood, and after renin-producing cell recruitment in response angiotensin-converting enzyme inhibition, we have confirmed the expression of 36 new genes (Table 3 ) in this unique cell type. As a result, we propose the PDGFB-PDGFRβ signaling pathway as a promising novel pathway that controls the developmental plasticity of juxtaglomerular cells.
